Yalikun, K., Li, Z., Zhang, J., Chang, Z., Li, M., Sun, Z., . . . Zhao, L. Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: A single-arm exploratory trial. BMC.
Chicago Style (17th ed.) CitationYalikun, Kugeluke, et al. Hepatic Artery Infusion Chemotherapy Combined with Camrelizumab and Apatinib as Conversion Therapy for Patients with Unresectable Hepatocellular Carcinoma: A Single-arm Exploratory Trial. BMC.
MLA (9th ed.) CitationYalikun, Kugeluke, et al. Hepatic Artery Infusion Chemotherapy Combined with Camrelizumab and Apatinib as Conversion Therapy for Patients with Unresectable Hepatocellular Carcinoma: A Single-arm Exploratory Trial. BMC.
Warning: These citations may not always be 100% accurate.